Tower Research Capital LLC (Trc) Immatics N.V. Transaction History
Tower Research Capital LLC (Trc)
- $3.53 Billion
- Q2 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Immatics N.V. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,081 shares of IMTX stock, worth $9,437. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,081Holding current value
$9,437% of portfolio
0.0%Shares
15 transactions
Others Institutions Holding IMTX
# of Institutions
74Shares Held
93.6MCall Options Held
158KPut Options Held
0-
T. Rowe Price Investment Management, Inc. Baltimore, MD18.3MShares$160 Million0.06% of portfolio
-
Suvretta Capital Management, LLC New York, NY12MShares$105 Million2.23% of portfolio
-
Baker Bros. Advisors LP New York, NY10.2MShares$88.8 Million0.55% of portfolio
-
Perceptive Advisors LLC New York, NY9.38MShares$81.9 Million2.22% of portfolio
-
Rtw Investments, LP New York, NY6.97MShares$60.8 Million0.58% of portfolio
About Immatics N.V.
- Ticker IMTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,227,000
- Market Cap $665M
- Description
- Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...